Intranasal octenidine for methicillin-resistant Staphylococcus aureus (MRSA) carriers and universal octenidine bathing reduced MRSA acquisition in an acute-care general ward. (16th November 2022)

• Record Type: Journal Article
• Authors: Aung, Aung-Hein; Kyaw, Win Mar; Heng, Yee Kiat; Tey, Hong Liang; Ang, Brenda; Chow, Angela
• Is Part Of: Infection control and hospital epidemiology. Volume 43:Number 11(2022)
• Page Start: 1701
• Page End: 1704
• Publication Date: 2022-11-16
• Subjects: Nosocomial infections -- Epidemiology -- Periodicals; Health facilities -- Sanitation -- Periodicals; Hospital buildings -- Sanitation -- Periodicals; Cross Infection -- Periodicals; Epidemiology -- Periodicals; Hospitals -- Periodicals; Infection Control -- Periodicals; 614.44
• DOI: 10.1017/ice.2021.300
• Languages: English
• ISSNs: 0899-823X

Abstract

Abstract: In this quasi-experimental before-and-after study in a methicillin-resistant staphylococcus aureus (MRSA) high-prevalence acute-care dermatology ward from August 2016 to November 2018, patients admitted during intervention period who received additional topical intranasal octenidine were 63% less likely to acquire MRSA than those receiving universal daily octenidine bathing alone during baseline period (aOR, 0.37; 95% CI, 0.14–0.98).